Romain T.
- Country
- France
- Department
- Cardiologie médicale et médecine vasculaire
Research Overview
- Comparison of Initial Dual Oral Therapy with Riociguat and Macitentan Versus Standard Monotherapy in Inoperable Chronic Thromboembolic Pulmonary Hypertension
- Evaluation of Sotatercept Pharmacokinetics and Safety in Pulmonary Arterial Hypertension Patients Undergoing Standard of Care Treatment
- Evaluation of Long-term Safety and Tolerability of Sotatercept (MK-7962) in Patients with Pulmonary Arterial Hypertension on Standard Care
Data & Insights
Has run more than one trial at 40 of 72 partner sites.
Specializations
Pulmonary Vascular Disorders
This investigator specializes in various forms of pulmonary hypertension, with particular emphasis on complex vascular conditions affecting the lungs.
- Pulmonary Arterial Hypertension (PAH)
- Chronic Thromboembolic Pulmonary Hypertension
- PH-COPD
The investigator focuses on evaluating innovative therapeutic approaches for these challenging pulmonary conditions.
Advanced Therapeutics
The investigator's work encompasses the evaluation of novel therapeutic agents for pulmonary vascular diseases, including:
- Dual oral treatment strategies
- Monotherapy approaches
- Weight-based dosing protocols
Their research includes assessment of treatment efficacy in inoperable conditions and treatment-naïve patients.
Clinical Assessments
The investigator conducts comprehensive evaluations focusing on:
- Pulmonary vascular resistance
- Systemic exposure measurements
- Long-term safety assessments
Their work involves monitoring therapeutic responses in complex pulmonary vascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.